Personal information

No personal information available

Activities

Collapse all

Works (26)

Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study‐5 and Children's Oncology Group Study AREN0321

Pediatric Blood & Cancer
2025-03 | Journal article
DOI: 10.1002/pbc.31490
Contributors: James I. Geller; Lindsay A. Renfro; Paul E. Grundy; Elizabeth J. Perlman; John A. Kalapurakal; Peter F. Ehrlich; Jackie Biegel; Vicki Huff; Anne B. Warwick; Arnold Paulino et al.
Source: check_circle
Crossref

Feasibility and Safety of Intratympanic Administration of Sustained‐Exposure Dexamethasone Thermosensitive Gel (OTO‐104) for Prevention of Cisplatin‐Induced Hearing Loss in Children: A Multisite Phase 2 Randomized Clinical Trial

Pediatric Blood & Cancer
2025-03-24 | Journal article
DOI: 10.1002/pbc.31680
Contributors: David R. Freyer; Timothy J. D. Ohlsen; Debra Don; Etan Orgel; Robert J. Hayashi; Judith E. Lieu; Jennifer H. Foster; Matthew S. Sitton; James I. Geller; Daniel I. Choo et al.
Source: check_circle
Crossref

Characteristics of patients with liver tumors deemed ineligible for enrollment on Children's Oncology Group trial AHEP1531: An opportunity to expand inclusion criteria and improve outcome

Pediatric Blood & Cancer
2025-01 | Journal article
DOI: 10.1002/pbc.31389
Contributors: Angela D. Trobaugh‐Lotrario; Allison F. O'Neill; Katelyn A. Belmonte; Marcio H. Malogolowkin; Greg M. Tiao; James I. Geller
Source: check_circle
Crossref

Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies

Cancer
2025-01-15 | Journal article
DOI: 10.1002/cncr.35713
Contributors: Amy E. Armstrong; Najat C. Daw; Lindsay A. Renfro; James I. Geller; John A. Kalapurakal; Geetika Khanna; Arnold C. Paulino; Elizabeth J. Perlman; Peter F. Ehrlich; Kenneth W. Gow et al.
Source: check_circle
Crossref

Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children’s Oncology Group Studies AREN03B2 and AREN0532

Cancer
2024-03 | Journal article
DOI: 10.1002/cncr.35084
Contributors: Nicholas Evageliou; Lindsay A. Renfro; James Geller; Elizabeth Perlman; John Kalapurakal; Arnold Paulino; David Dix; Meryle J. Eklund; Andrew J. Murphy; Rodrigo L. P. Romao et al.
Source: check_circle
Crossref

EZH2 is a key component of hepatoblastoma tumor cell growth

Pediatric Blood & Cancer
2024-02 | Journal article
DOI: 10.1002/pbc.30774
Contributors: Kathryn Glaser; Emily J. Schepers; Harrison M. Zwolshen; Charissa M. Lake; Nikolai A. Timchenko; Rebekah A. Karns; Stefano Cairo; James I. Geller; Gregory M. Tiao; Alexander J. Bondoc
Source: check_circle
Crossref

Second Primary Malignant Neoplasms in Survivors of Retinoblastoma in a Single Ocular Oncology Practice

2024-01-05 | Preprint
DOI: 10.22541/au.170444530.01337137/v1
Contributors: Malcolm T. Wiseman; Jared J. Ebert; James J. Augsburger; Maura Nicola; Zelia M. Correa; James Geller; Basil K. Williams
Source: check_circle
Crossref

Children's Oncology Group's 2023 blueprint for research: Liver tumors

Pediatric Blood & Cancer
2023-09 | Journal article
DOI: 10.1002/pbc.30576
Contributors: Allison F. O'Neill; Rebecka L. Meyers; Howard M. Katzenstein; James I. Geller; Greg M. Tiao; Dolores López‐Terrada; Marcio Malogolowkin
Source: check_circle
Crossref

Children's Oncology Group's 2023 blueprint for research: Renal tumors

Pediatric Blood & Cancer
2023-09 | Journal article
DOI: 10.1002/pbc.30586
Contributors: James I. Geller; Andrew L. Hong; Kelly L. Vallance; Nick Evageliou; Jennifer H. Aldrink; Nicholas G. Cost; Amy L. Treece; Lindsay A. Renfro; Elizabeth A. Mullen
Source: check_circle
Crossref

Progress by international collaboration for pediatric renal tumors by HARMONIzation and COllaboration: The HARMONICA initiative

Pediatric Blood & Cancer
2023-05 | Journal article
DOI: 10.1002/pbc.30082
Contributors: M. M. van den Heuvel‐Eibrink; C. V. Fernandez; N. Graf; James I. Geller
Source: check_circle
Crossref

Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it

Pediatric Blood & Cancer
2023-05 | Journal article
DOI: 10.1002/pbc.30248
Contributors: Penelope Brock; Annelot Meijer; Per Kogner; Marc Ansari; Michael Capra; James Geller; Marry van den Heuvel‐Eibrink; Kristin Knight; Mariana Kruger; Susan Lindemulder et al.
Source: check_circle
Crossref

Ocular survival after intra‐arterial chemotherapy for retinoblastoma improves with accrual of experience and programmatic evolution

Pediatric Blood & Cancer
2023-02 | Journal article
DOI: 10.1002/pbc.30071
Contributors: Stefan A. Marasligiller; Basil K. Williams; Sudhakar Vadivelu; Zelia M. Correa; Todd A. Abruzzo; Maura Di Nicola; Adam Lane; James I. Geller
Source: check_circle
Crossref

Progress by international collaboration for pediatric renal tumors by HARMONIsation and Collaboration: the HARMONICA initiative

2022-10-11 | Preprint
DOI: 10.22541/au.166548783.38480442/v1
Contributors: James Geller; Marry Van den Heuvel-Eibrink; Conrad Fernandez; Norbert Graf
Source: check_circle
Crossref

Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma

American Journal of Neuroradiology
2021-02-24 | Journal article
DOI: 10.3174/ajnr.A6905
Contributors: T. Abruzzo; K. Abraham; K.B. Karani; J.I. Geller; S. Vadivelu; J.M. Racadio; B. Zhang; Z.M. Correa
Source: check_circle
Crossref

A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study

Cancer
2020-12 | Journal article
DOI: 10.1002/cncr.33173
Contributors: James I. Geller; Nicholas G. Cost; Yueh‐Yun Chi; Brett Tornwall; Mariana Cajaiba; Elizabeth J. Perlman; Yeonil Kim; Elizabeth A. Mullen; Richard D. Glick; Geetika Khanna et al.
Source: check_circle
Crossref

ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma—A Children's Oncology Group study

Cancer
2020-12-15 | Journal article
DOI: 10.1002/cncr.33195
Contributors: James I. Geller; Joseph G. Pressey; Malcolm A. Smith; Rachel A. Kudgus; Mariana Cajaiba; Joel M. Reid; David Hall; Donald A. Barkauskas; Stephen D. Voss; Steve Y. Cho et al.
Source: check_circle
Crossref

Reducing acute kidney injury in pediatric oncology patients: An improvement project targeting nephrotoxic medications

Pediatric Blood & Cancer
2020-08 | Journal article
DOI: 10.1002/pbc.28396
Contributors: Jennifer Young; Devesh Dahale; Kathleen Demmel; Maureen O'Brien; James Geller; Josh Courter; David B. Haslam; Lara Danziger‐Isakov; Stuart L. Goldstein
Source: check_circle
Crossref

Clinical heterogeneity of pediatric hepatocellular carcinoma

Pediatric Blood & Cancer
2020-06 | Journal article
DOI: 10.1002/pbc.28307
Contributors: Amber M. D'Souza; Alexander J. Towbin; Anita Gupta; Maria Alonso; Jaimie D. Nathan; Alex Bondoc; Greg Tiao; James I. Geller
Source: check_circle
Crossref

Treatment of advanced pediatric renal cell carcinoma

Pediatric Blood & Cancer
2019-08 | Journal article
DOI: 10.1002/pbc.27766
Contributors: Manoj Ambalavanan; James I. Geller
Source: check_circle
Crossref

Transarterial radioembolization with yttrium‐90 of unresectable primary hepatic malignancy in children

Pediatric Blood & Cancer
2019-07 | Journal article
DOI: 10.1002/pbc.27510
Contributors: Allison Aguado; Ross Ristagno; Alexander J. Towbin; Anita Gupta; Sinisa Haberle; Zhihua Qi; Manish N. Patel; Kamlesh U. Kukreja; Gregory M. Tiao; James I. Geller
Source: check_circle
Crossref

Surgical and anesthetic management for hepatectomy in two pediatric patients with trisomy 18, pulmonary hypertension, and hepatoblastoma

Pediatric Blood & Cancer
2019-06 | Journal article
DOI: 10.1002/pbc.27678
Contributors: Donald J. Lucas; Jeremy Rubinstein; Ankush Gosain; Greg Tiao; Tim Head; J. Nick Pratap; Regan Williams; Sara Helmig; James Geller; Max Langham et al.
Source: check_circle
Crossref

Dose modifications and pharmacokinetics of adjuvant cisplatin monotherapy while on hemodialysis for patients with hepatoblastoma

Pediatric Blood & Cancer
2019-01 | Journal article
DOI: 10.1002/pbc.27425
Contributors: Alexander A. Boucher; Tomoyuki Mizuno; Alexander A. Vinks; Stuart L. Goldstein; Greg M. Tiao; James I. Geller
Source: check_circle
Crossref

Acquired ornithine transcarbamylase deficiency in pediatric and adolescent patients with fibrolamellar hepatocellular carcinoma

Pediatric Blood & Cancer
2018-12 | Journal article
DOI: 10.1002/pbc.27392
Contributors: Allison L. Bartlett; Nancy D. Leslie; Anita Gupta; James I. Geller
Source: check_circle
Crossref

Surgical management of children and adolescents with upfront completely resected hepatocellular carcinoma

Pediatric Blood & Cancer
2018-11 | Journal article
DOI: 10.1002/pbc.27293
Contributors: Amber M. D'Souza; Rachana Shah; Anita Gupta; Alexander J. Towbin; Maria Alonso; Jaimie D. Nathan; Alex Bondoc; Greg Tiao; James I. Geller
Source: check_circle
Crossref

The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing

Cancer
2018-08-15 | Journal article
DOI: 10.1002/cncr.31578
Contributors: Mariana M. Cajaiba; Lisa M. Dyer; James I. Geller; Lawrence J. Jennings; David George; Dawn Kirschmann; Stephen M. Rohan; Nicholas G. Cost; Geetika Khanna; Elizabeth A. Mullen et al.
Source: check_circle
Crossref

Germline APC mutations in hepatoblastoma

Pediatric Blood & Cancer
2018-04 | Journal article
DOI: 10.1002/pbc.26892
Contributors: Adeline Yang; Rebecca Sisson; Anita Gupta; Greg Tiao; James I. Geller
Source: check_circle
Crossref

Peer review (2 reviews for 2 publications/grants)

Review activity for Cell reports medicine. (1)
Review activity for Urologic oncology. (1)
How many people are using ORCID?